Carlos Campoy
2021
In 2021, Carlos Campoy earned a total compensation of $1.4M as Senior Vice President, Chief Financial Officer at CytomX Therapeutics, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,797 |
|---|---|
| Option Awards | $557,652 |
| Salary | $477,555 |
| Stock Awards | $160,200 |
| Other | $5,000 |
| Total | $1,396,204 |
Campoy received $557.7K in option awards, accounting for 40% of the total pay in 2021.
Campoy also received $195.8K in non-equity incentive plan, $477.6K in salary, $160.2K in stock awards and $5K in other compensation.
Rankings
In 2021, Carlos Campoy's compensation ranked 7,560th out of 12,415 executives tracked by ExecPay. In other words, Campoy earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,560 out of 12,415 | 39th |
Division Manufacturing | 3,329 out of 5,508 | 40th |
Major group Chemicals And Allied Products | 1,476 out of 2,378 | 38th |
Industry group Drugs | 1,314 out of 2,099 | 37th |
Industry Pharmaceutical Preparations | 970 out of 1,549 | 37th |
Source: SEC filing on April 27, 2022.
Campoy's colleagues
We found five more compensation records of executives who worked with Carlos Campoy at CytomX Therapeutics in 2021.
2021
Sean McCarthy
CytomX Therapeutics
Chief Executive Officer
2021
Amy Peterson
CytomX Therapeutics
Chief Operating Officer
2021
Jeff Landau
CytomX Therapeutics
Senior Vice President and Chief Business Officer
2021
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
2021
Lloyd Rowland
CytomX Therapeutics